Skip to main content
. 2009 Jun 17;27(35):4840–4849. doi: 10.1016/j.vaccine.2009.05.093

Table 1.

Humoral immune response end-point titers.a.

Groups Week 16 Week 38
2 weeks post vaccination #3 2 weeks post vaccination #5
pCMV-gag.kan (n = 11) <1:100 1:2700
pCMV-LAMP/gag.kan (n = 11) 1:2700 1:8100
a

End-point titer of pooled plasma at weeks 16 and 38, after 3rd and 5th DNA immunizations, respectively. The reported titers correspond to the reciprocal of the highest serum dilution that gave a three times higher OD value than the corresponding dilution of a non-immune serum.